Innovative Solutions & Services
Creative Problem Solving for Medical Device and Drug Delivery Challenges
PharmaPack 2024 Jan 24-25th in Paris
Focus Areas
Revolutionary design-thinking to drive Innovation and bring novel surgical solutions into the world.
OPHTHALMIC
Surgical Instrumentation
A deep and trusted heritage innovating for improved ophthalmic outcomes.
DRUG DELIVERY
Devices & Components
An expansive portfolio of Next-Gen drug delivery solutions and services.
IMPLANT DELIVERY
Devices & Components
Next-Gen solutions to enable easy implant insertion with precision and accuracy.
Focused Areas of
Excellence
CUSTOMIZABLE
Platforms
Tested
Accelerators
Combined Years of
Experience
Let’s Talk Delivery Platforms
Innovative, fully integrated systems for immediate use or rapid customization.
AltaVISC - Auto-Injector
With the power to deliver high viscosity, large volume formulations in short or programmed periods of time, new biologic drug-compatible auto-injectors benefit from the power of Pico-Cylinders.
FLUID INJECTOR
The Fluid Injector combines a disposable, self-powered syringe driver with sub-microliter dose tracking and highly repeatable delivery rates. As a versatile injection platform, this device can be loaded with any therapeutic agent at time of use, handling any fluid viscosity.
Gas INJECTOR
The gas injector platform delivers high purity medical gases contained in a valved Pico-Cylinder, and can be designed with a wide range of features like mixed or 100% pure gas delivery.
Implant Delivery
Gas-power enables the implant delivery platform to provide single-use, single handed automated implant insertion with smooth, silent and precise operation
PRESS RELEASE
Altaviz Gaining Strong Market Traction with Advent R400e, an Evolutionary Delivery Solution for Subretinal Gene Therapy
IRVINE, CA – November 9, 2021, Altaviz, a designer, developer and manufacturer of medical devices and drug delivery platforms, has increased its organizational focus with the development of the Advent R400e, their groundbreaking delivery solution for subretinal gene therapy. Since announcing the development of this evolutionary delivery platform in July 2021, Altaviz has experienced strong new business opportunities and is currently working with multiple organizations who are leaders in the sub-retinal gene and drug delivery market.
Get to know our latest solution
Advent R400e
A Delivery Solution for Subretinal Gene Therapy
Uniquely designed for the delivery of life-changing therapies, including gene therapy, stem cell therapy and biologic, take a minute to learn about the game changing Advent R400e!
Innovation in everything we do.
Our mission at Altaviz is to partner with innovative medical, pharmaceutical and biotech companies to develop and commercialize state-of-the-art drug and implant delivery solutions ranging from compact auto injectors and single use implant inserters to console level systems management
These medical devices utilize our cutting edge intellectual property and are powered by innovative embedded power cells. Altaviz intellectual property, platform technologies and delivery systems provide our customers with the flexibility to accommodate the latest market trends, with next-gen delivery solutions to meet demanding requirements.
TECHNOLOGY SPOTLIGHT
Harnessing the Power of Gas
After decades of limited options to power drug delivery devices, the next generation has arrived.
Medical-grade compressed gas cylinders represent the next innovation in drug delivery device power sources. This ground-breaking technology and expansive field of application offers a new realm of injection platform capability and flexibility.
Altaviz is the Creator of the Pico-Cylinder, Learn More
Note: this link will take you to Picocyl.com, our sister company.
“I just wanted to take a moment to thank you for all the hard work that is going into this device to make it a great and reliable product. We do realize and appreciate all that you have been able to accomplish. Our GM got to personally use one of your working prototypes and was impressed. Additionally, the Board of Directors has also taken an interest in this project. Keep up the good work and please pass this along to others I have missed!”